Does changing healthcare use signal opportunities for earlier detection of cancer? A review of studies using information from electronic patient records
- PMID: 34876377
- PMCID: PMC8785122
- DOI: 10.1016/j.canep.2021.102072
Does changing healthcare use signal opportunities for earlier detection of cancer? A review of studies using information from electronic patient records
Abstract
Background: It has been proposed that changes in healthcare use before cancer diagnosis could signal opportunities for quicker detection, but systematic appreciation of such evidence is lacking. We reviewed studies examining pre-diagnostic changes in healthcare utilisation (e.g. rates of GP or hospital consultations, prescriptions or diagnostic tests) among patients subsequently diagnosed with cancer.
Methods: We identified studies through Pubmed searches complemented by expert elicitation. We extracted information on the earliest time point when diagnosis could have been possible for at least some cancers, together with variation in the length of such 'diagnostic windows' by tumour and patient characteristics.
Results: Across twenty-eight studies, changes in healthcare use were observable at least six months pre-diagnosis for many common cancers, and potentially even earlier for colorectal cancer, multiple myeloma and brain tumours. Early changes were also identified for brain and colon cancer sub-sites.
Conclusion: Changing healthcare utilisation patterns before diagnosis indicate that future improvements in diagnostic technologies or services could help to shorten diagnostic intervals for cancer. There is greatest potential for quicker diagnosis for certain cancer types and patient groups, which can inform priorities for the development of decision support tools.
Keywords: Early detection of cancer[MeSH Term]; Early diagnosis; Health records; Healthcare use; Signs and symptoms[MeSH Term].
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures



Similar articles
-
Diagnostic windows in non-neoplastic diseases: a systematic review.Br J Gen Pract. 2023 Aug 31;73(734):e702-e709. doi: 10.3399/BJGP.2023.0044. Print 2023 Sep. Br J Gen Pract. 2023. PMID: 37308303 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.Health Technol Assess. 2020 Nov;24(66):1-332. doi: 10.3310/hta24660. Health Technol Assess. 2020. PMID: 33252328 Free PMC article.
-
Multi-cancer early detection tests for general population screening: a systematic literature review.Health Technol Assess. 2025 Jan;29(2):1-105. doi: 10.3310/DLMT1294. Health Technol Assess. 2025. PMID: 39898371 Free PMC article.
-
Trends in time to cancer diagnosis around the period of changing national guidance on referral of symptomatic patients: A serial cross-sectional study using UK electronic healthcare records from 2006-17.Cancer Epidemiol. 2020 Dec;69:101805. doi: 10.1016/j.canep.2020.101805. Epub 2020 Sep 9. Cancer Epidemiol. 2020. PMID: 32919226 Free PMC article.
Cited by
-
A taxonomy of early diagnosis research to guide study design and funding prioritisation.Br J Cancer. 2023 Nov;129(10):1527-1534. doi: 10.1038/s41416-023-02450-4. Epub 2023 Oct 4. Br J Cancer. 2023. PMID: 37794179 Free PMC article. Review.
-
A UK population-based case-control study of blood tests before cancer diagnosis in patients with non-specific abdominal symptoms.Br J Cancer. 2025 Mar;132(5):450-461. doi: 10.1038/s41416-024-02936-9. Epub 2025 Jan 11. Br J Cancer. 2025. PMID: 39799273 Free PMC article.
-
Diagnostic windows in non-neoplastic diseases: a systematic review.Br J Gen Pract. 2023 Aug 31;73(734):e702-e709. doi: 10.3399/BJGP.2023.0044. Print 2023 Sep. Br J Gen Pract. 2023. PMID: 37308303 Free PMC article.
-
Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.JCO Precis Oncol. 2023 Jul;7:e2200679. doi: 10.1200/PO.22.00679. JCO Precis Oncol. 2023. PMID: 37467458 Free PMC article. Clinical Trial.
-
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy.Front Immunol. 2023 Mar 10;14:1133050. doi: 10.3389/fimmu.2023.1133050. eCollection 2023. Front Immunol. 2023. PMID: 36969211 Free PMC article. Review.
References
-
- Tørring M.L., Falborg A.Z., Jensen H., Neal R.D., Weller D., Reguilon I., Menon U., Vedsted P., Almberg S.S., Anandan C., Barisic A., Boylan J., Cairnduff V., Donnelly C., Fourkala E.O., Gavin A., Grunfeld E., Hammersley V., Hawryluk B., Kearney T., Kelly J., Knudsen A.K., Lambe M., Law R., Lin Y., Malmberg M., Moore K., Turner D., White V. Advanced‐stage cancer and time to diagnosis: an international cancer benchmarking partnership (ICBP) cross‐sectional study. Eur. J. Cancer Care. 2019;28 doi: 10.1111/ecc.13100. - DOI - PubMed
-
- Neal R.D., Tharmanathan P., France B., Din N.U., Cotton S., Fallon-Ferguson J., Hamilton W., Hendry A., Hendry M., Lewis R., Macleod U., Mitchell E.D., Pickett M., Rai T., Shaw K., Stuart N., Tørring M.L., Wilkinson C., Williams B., Williams N., Emery J. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? systematic review. Br. J. Cancer. 2015;112:S92–S107. doi: 10.1038/bjc.2015.48. - DOI - PMC - PubMed
-
- Tørring M.L., Murchie P., Hamilton W., Vedsted P., Esteva M., Lautrup M., Winget M., Rubin G. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries. Br. J. Cancer. 2017;117:888–897. doi: 10.1038/bjc.2017.236. - DOI - PMC - PubMed
-
- Mendonca S.C., Abel G.A., Saunders C.L., Wardle J., Lyratzopoulos G. Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the english cancer patient experience survey. Eur. J. Cancer Care. 2016;25:478–490. doi: 10.1111/ecc.12353. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical